Breaking News
Thursday , November 23 2017
Home / Tag Archives: Suven Life Sciences

Tag Archives: Suven Life Sciences

Suven Life Sciences initiates Phase 1 clinical trial of SUVN-911

Suven Life Sciences’ NCESUVN-911, a potent, selective, brain penetrant and orally active, novel chemical entity intended for the treatment of major depressive disorder (MDD) has initiated Phase 1 development and first dosing under US IND 133850 and the topline results from the study is expected during the quarter Jan-March 2018. ... Read More »

Suven Life Sciences reports 8% rise in Q4 net profit

Life Sciences has reported results for the fourth quarter and year ended March 31, 2017. The company has reported a rise of 7.77% in its net profit at Rs 40.07 crore for the quarter ended March 31, 2017 as compared to Rs 37.18 crore for the same quarter in the ... Read More »